Cadre Holdings, Inc. income statement CDRE

In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, Cadre Holdings, Inc. reported revenue of $202.9 million, up 30.2% from the same quarter a year earlier. Net income was $16.0 million, a profit margin of 7.9%. Operating income came to $28.4 million, an operating margin of 14.0%. Diluted earnings per share were $0.37.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

Line
TTM
Sep 30, 2026
Q3 FY2026
Sep 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Q1 FY2025
Mar 31, 2025
Q4 FY2024
Dec 31, 2024
Revenue
733
+18.3%
203
+30.2%
207
+31.8%
155
+19.5%
167
-5.0%
156
+42.5%
157
+8.9%
130
-5.6%
176
+41.3%
Cost of revenue
425
+19.7%
115
+28.6%
120
+29.2%
95
+28.8%
95
-4.2%
89
+28.6%
93
+8.4%
74
-7.8%
99
+32.0%
Gross profit
308
+16.6%
88
+32.2%
87
+35.6%
60
+7.2%
73
-5.9%
67
+66.5%
64
+9.5%
56
-2.6%
77
+55.1%
Selling, general and administrative
222
+24.8%
59
+29.0%
63
+40.1%
49
+17.0%
51
+12.4%
46
+34.3%
45
+17.0%
42
+2.5%
45
+29.1%
Operating income
79
+3.2%
28
+51.8%
22
+53.0%
7
-44.7%
20
-30.5%
19
+244.2%
15
-26.4%
14
+13.1%
29
+131.9%
Other income (expense)
-17
-94.7%
-4
-15.4%
-6
-319.8%
-5
-393.6%
-3
+58.5%
-4
-778.4%
3
+207.9%
-1
+69.4%
-7
-2442.6%
Pretax income
61
-9.0%
24
+61.2%
17
-1.7%
3
-77.5%
18
-22.2%
15
+197.5%
17
-2.3%
13
+41.7%
23
+83.0%
Income tax
20
-8.0%
8
+103.6%
6
+10.2%
1
-74.5%
6
-39.1%
4
+192.4%
5
-1.0%
3
+70.6%
10
+245.1%
Net income
41
-9.4%
16
+46.1%
11
-6.6%
2
-78.6%
12
-9.6%
11
+199.3%
12
-2.8%
9
+33.5%
13
+35.3%
Basic EPS
0.97
-13.3%
0.37
+37.0%
0.27
-10.0%
0.05
-78.3%
0.28
-11.6%
0.27
+200.0%
0.30
-3.2%
0.23
+27.8%
0.32
+25.3%
Diluted EPS
0.91
-18.0%
0.37
+37.0%
0.26
-13.3%
0.05
-78.3%
0.23
-27.0%
0.27
+200.0%
0.30
-3.2%
0.23
+27.8%
0.32
+26.1%
Weighted average shares, basic
42
+4.4%
43
+5.4%
43
+5.3%
43
+4.8%
42
+2.2%
41
+0.1%
41
+0.1%
41
+7.0%
41
+8.0%
Weighted average shares, diluted
45
+10.5%
43
+6.1%
43
+6.0%
43
+5.8%
51
+23.8%
41
+0.1%
41
+0.2%
41
+6.3%
41
+7.3%
Other measures
Depreciation and amortization
23
+28.1%
6
+19.7%
6
+32.0%
6
+48.5%
5
+15.4%
5
+42.9%
5
+1.2%
4
-2.2%
4
+22.2%
EBITDA
102
+7.9%
35
+44.6%
29
+47.9%
13
-24.1%
25
-24.9%
24
+161.7%
19
-21.2%
17
+9.3%
33
+109.0%
Interest coverage
—
—
—
—
—
—
4.09x
6.07x
13.42x
Margins
Gross margin
42.04%
43.42%
42.07%
38.71%
43.43%
42.74%
40.89%
43.14%
43.86%
Operating margin
10.75%
13.97%
10.84%
4.82%
12.22%
11.98%
9.35%
10.42%
16.71%
Pretax margin
8.37%
11.80%
8.17%
1.82%
10.56%
9.52%
10.95%
9.69%
12.91%
Profit margin
5.61%
7.88%
5.51%
1.27%
7.02%
7.02%
7.77%
7.11%
7.38%
EBITDA margin
13.90%
17.15%
13.82%
8.50%
15.05%
15.43%
12.32%
13.38%
19.03%
Effective tax rate
32.99%
33.20%
32.56%
30.24%
33.55%
26.29%
29.04%
26.65%
42.85%
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
CDRE (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Jacksonville, FL
SEC filer status
Accelerated filer, Emerging growth company
SEC CIK
1860543

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.